Interactions between the gut microbiome and mucosal immunoglobulins A, M, and G in the developing infant gut

TEDDY Study Group

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

Interactions between the gut microbiome and immunoglobulin A (IgA) in the gut during infancy are important for future health. IgM and IgG are also present in the gut; however, their interactions with the microbiome in the developing infant remain to be characterized. Using stool samples sampled 15 times in infancy from 32 healthy subjects at 4 locations in 3 countries, we characterized patterns of microbiome development in relation to fecal levels of IgA, IgG, and IgM. For 8 infants from a single location, we used fluorescence-activated cell sorting of microbial cells from stool by Ig-coating status over 18 months. We used 16S rRNA gene profiling on full and sorted microbiomes to assess patterns of antibody coating in relation to age and other factors. All antibodies decreased in concentration with age but were augmented by breastmilk feeding regardless of infant age. Levels of IgA correlated with relative abundances of operational taxonomic units (OTUs) belonging to the Bifidobacteria and Enterobacteriaceae, which dominated the early microbiome, and IgG levels correlated with Haemophilus. The diversity of Ig-coated microbiota was influenced by breastfeeding and age. IgA and IgM coated the same microbiota, which reflected the overall diversity of the microbiome, while IgG targeted a different subset. Blautia generally evaded antibody coating, while members of the Bifidobacteria and Enterobacteriaceae were high in IgA/M. IgA/M displayed similar dynamics, generally coating the microbiome proportionally, and were influenced by breastfeeding status. IgG only coated a small fraction of the commensal microbiota and differed from the proportion targeted by IgA and IgM. Importance: Antibodies are secreted into the gut and attach to roughly half of the trillions of bacterial cells present. When babies are born, the breastmilk supplies these antibodies until the baby's own immune system takes over this task after a few weeks. The vast majority of these antibodies are IgA, but two other types, IgG and IgM, are also present in the gut. Here, we ask if these three different antibody types target different types of bacteria in the infant gut as the infant develops from birth to 18 months old and how patterns of antibody coating of bacteria change with age. In this study of healthy infant samples over time, we found that IgA and IgM coat the same bacteria, which are generally representative of the diversity present, with a few exceptions that were more or less antibody coated than expected. IgG coated a separate suite of bacteria. These results provide a better understanding of how these antibodies interact with the developing infant gut microbiome.

Original languageEnglish
Article numbere00612
JournalmSystems
Volume4
Issue number6
DOIs
StatePublished - 2019

Bibliographical note

Publisher Copyright:
Copyright © 2019 Janzon et al.

Funding

This work was supported by a National Science Foundation Graduate Fellowship (J.K.G.), Swedish Research Council grant 2011-922 (A.J.), and the Max Planck Society (R.E.L.). The TEDDY study is funded by U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, and contract no. HHSN267200700014C from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Juvenile Diabetes Research Foundation (JDRF), and Centers for Disease Control and Prevention (CDC). This work was supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida (UL1 TR000064) and the University of Colorado (UL1 TR001082). We thank William Melvin and Wei Zhang at Cornell University for their assistance. Special thanks to Timothy Bushnell, Matthew Cochran, and staff at the Flow Cytometry Core at the University of Rochester Medical Center. This work was supported by a National Science Foundation Graduate Fellowship (J.K.G.), Swedish Research Council grant 2011-922 (A.J.), and the Max Planck Society (R.E.L.). The TEDDY study is funded by U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, and contract no. HHSN267200700014C from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Juvenile Diabetes Research Foundation (JDRF), and Centers for Disease Control and Prevention (CDC). This work was supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida (UL1 TR000064) and the University of Colorado (UL1 TR001082).

FundersFunder number
NIH/NCATS
National Science Foundation
Centers for Disease Control and Prevention
National Institute of Allergy and Infectious Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Child Health and Human Development
University of FloridaUL1 TR000064
Medical Center, University of Rochester
University of ColoradoUL1 TR001082
Juvenile Diabetes Research Foundation Australia
Max-Planck-GesellschaftU01 DK63863, U01 DK63861, UC4 DK95300, U01 DK63790, UC4 DK63829, U01 DK63836, UC4 DK100238, UC4 DK106955, U01 DK63821, U01 DK63865, UC4 DK63821, UC4 DK63865, UC4 DK63836, U01 DK63829, HHSN267200700014C, UC4 DK63861, UC4 DK63863
Vetenskapsrådet2011-922

    Keywords

    • Antibody coating
    • Diabetes
    • FACS
    • Gut microbiome
    • Host response
    • IgA
    • IgG
    • IgM
    • Immunoglobulins
    • Immunology
    • Infant
    • Infant gut development
    • Microbial ecology

    Fingerprint

    Dive into the research topics of 'Interactions between the gut microbiome and mucosal immunoglobulins A, M, and G in the developing infant gut'. Together they form a unique fingerprint.

    Cite this